Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Respiratory Distress Syndrome 1Prostatic Neoplasms 1Pneumonia, Viral 1Oligodendroglioma 1Melanoma 1Hodgkin Disease 1High-Grade Anal Intraepithelial Neoplasia 1Hematologic Neoplasms 1HIV Infections 1Gliosarcoma 1Glioma 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Ependymoma 1Cytokine Release Syndrome 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Astrocytoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Lopinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × High-Grade Anal Intraepithelial Neoplasia × Lopinavir × Clear all
NCT05334004 2026-05-15

Lopinavir/Ritonavir in PLWH With High-Grade AIN

University of Wisconsin, Madison

Phase 1 Recruiting
21 enrolled

High-Grade Anal Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡